Meyka Pro banner
Zoetis Inc.

Zoetis Inc. (ZTS) Stock Overview

Explore Zoetis Inc.’s financial performance, market position, analyst ratings, and future outlook.

ZTSNYSE
HealthcareDrug Manufacturers - General
$77.73
$2.71(3.61%)
U.S. Market opens in 62h 59m

Zoetis Inc. (ZTS)

Meyka AI Score

Z

Key Financials

Market Cap32.6B
P/E Ratio12.80
EPS (TTM)$6.58
ROE0.69%
Fundamental Analysis

AI Price Forecasts

1 Month$70.37
3 Months$41.70
1 Year Target$71.70

ZTS Stock Analysis & Investment Overview (NYSE)

Our AI-powered analysis of Zoetis Inc. (NYSE: ZTS) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Zoetis Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ZTS on the NYSE shows an RSI of 54.92, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $71.70 for the NYSE listing.

Key metrics behind Zoetis Inc.'s NYSE-traded stock include a P/E ratio of 12.80 and a market capitalization of 32.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ZTS on the NYSE.

Price Performance (NYSE: ZTS)

1-Day Change
3.63%
5-Day Change
2.94%
1-Month Change
3.17%
3-Month Change
-2.91%
6-Month Change
-39.63%
Year-to-Date (YTD) Change
-38.21%
1-Year Change
-50.04%
3-Year Change
-57.00%
5-Year Change
-62.35%
All-Time (Max) Change
150.69%

Contact Information

973 822 7000
10 Sylvan Way, Parsippany, NJ, 07054

Company Facts

145,000 Employees
IPO DateFeb 1, 2013
CountryUS
Actively Trading

Frequently Asked Questions